NM_003227.4:c.1995+9G>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003227.4(TFR2):​c.1995+9G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00304 in 1,548,962 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 5 hom. )

Consequence

TFR2
NM_003227.4 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.336

Publications

0 publications found
Variant links:
Genes affected
TFR2 (HGNC:11762): (transferrin receptor 2) This gene encodes a single-pass type II membrane protein, which is a member of the transferrin receptor-like family. This protein mediates cellular uptake of transferrin-bound iron, and may be involved in iron metabolism, hepatocyte function and erythrocyte differentiation. Mutations in this gene have been associated with hereditary hemochromatosis type III. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
TFR2 Gene-Disease associations (from GenCC):
  • hemochromatosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 7-100627255-C-G is Benign according to our data. Variant chr7-100627255-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 221011.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00204 (310/152322) while in subpopulation NFE AF = 0.00341 (232/68018). AF 95% confidence interval is 0.00305. There are 0 homozygotes in GnomAd4. There are 139 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFR2NM_003227.4 linkc.1995+9G>C intron_variant Intron 16 of 17 ENST00000223051.8 NP_003218.2 Q9UP52-1
TFR2NM_001206855.3 linkc.1482+9G>C intron_variant Intron 13 of 14 NP_001193784.1 Q9UP52-2
LOC124901709XR_007060454.1 linkn.434-3901C>G intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFR2ENST00000223051.8 linkc.1995+9G>C intron_variant Intron 16 of 17 1 NM_003227.4 ENSP00000223051.3 Q9UP52-1

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
310
AN:
152204
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00358
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00341
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00182
AC:
273
AN:
150184
AF XY:
0.00175
show subpopulations
Gnomad AFR exome
AF:
0.000624
Gnomad AMR exome
AF:
0.000364
Gnomad ASJ exome
AF:
0.000119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00320
Gnomad NFE exome
AF:
0.00341
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00315
AC:
4399
AN:
1396640
Hom.:
5
Cov.:
34
AF XY:
0.00307
AC XY:
2113
AN XY:
688870
show subpopulations
African (AFR)
AF:
0.000381
AC:
12
AN:
31522
American (AMR)
AF:
0.000420
AC:
15
AN:
35686
Ashkenazi Jewish (ASJ)
AF:
0.000119
AC:
3
AN:
25170
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.000543
AC:
43
AN:
79136
European-Finnish (FIN)
AF:
0.00385
AC:
188
AN:
48840
Middle Eastern (MID)
AF:
0.000736
AC:
3
AN:
4074
European-Non Finnish (NFE)
AF:
0.00372
AC:
4009
AN:
1078686
Other (OTH)
AF:
0.00218
AC:
126
AN:
57792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
242
483
725
966
1208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00204
AC:
310
AN:
152322
Hom.:
0
Cov.:
33
AF XY:
0.00187
AC XY:
139
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41564
American (AMR)
AF:
0.000457
AC:
7
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.00358
AC:
38
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00341
AC:
232
AN:
68018
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00261
Hom.:
1
Bravo
AF:
0.00157

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hemochromatosis type 3 Uncertain:1Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Hereditary hemochromatosis Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
5.0
DANN
Benign
0.75
PhyloP100
-0.34
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41295921; hg19: chr7-100224878; API